Financials
Financial year 2025
APOTHEEK ROGGEN ZAVENTEM from Zaventem, company number BE0443149052, closed financial year 2025 with a result of € -15,411 after tax. For that financial year APOTHEEK ROGGEN ZAVENTEM recorded a gross margin of € 173,276 and equity of € 311,144. Compared with financial year 2024, the result moved from € 224 to € -15,411. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 13, 2026.
€ 311,144
▼ 5% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -15,411
▼ still € 224 profit in 2024
Profit after tax over the fiscal year.
€ 37,981
▼ 45% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 239,255.
People and assets in 2025
1.8
Average over the fiscal year, from the social balance sheet.
€ 148,976
▲ 5% vs 2024
€ 82,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
€ 213,807
▼ 8% vs 2024
€ 20,469 is repaid this year. At this pace the long-term loan is gone in ≈ 10 years.
€ 94,178
▼ 22% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 19,340
▲ 2% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 216,423 | € 168,703 | € 210,775 | € 173,276 | ▼ 18% |
| Profit after taxes | € 86,192 | € 16,757 | € 224 | € -15,411 | ▼ € 15,636 |
| Equity | € 334,574 | € 326,331 | € 326,555 | € 311,144 | ▼ 5% |
| Total debts | € 293,640 | € 265,601 | € 378,344 | € 332,060 | ▼ 12% |
| Cash | € 149,090 | € 122,965 | € 68,476 | € 37,981 | ▼ 45% |
| Land & buildings | € 172,390 | € 157,663 | € 297,482 | € 277,585 | ▼ 7% |
| Retained profit | € 262,685 | € 254,442 | € 254,666 | € 239,255 | ▼ 6% |
| Dividend | € 94,000 | € 25,000 | € 0 | € 0 | |
| Bank debt | € 127,628 | € 115,854 | € 233,526 | € 213,807 | ▼ 8% |
| Balance sheet total | € 628,214 | € 591,932 | € 704,899 | € 643,203 | ▼ 9% |
| Employees (FTE) | 1.4 | 1.6 | 1.8 | 1.8 |
Key figures of APOTHEEK ROGGEN ZAVENTEM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to APOTHEEK ROGGEN ZAVENTEM?
What happened at APOTHEEK ROGGEN ZAVENTEM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 15,411 (▼ € 15,636 vs 2024). filed late Source: NBB ↗
- New establishment in Zaventem. KBO
- Start of the company according to the CBE. KBO
In short
From € 86,192 profit in 2022 to € 15,411 loss in 2025.
Paid € 7,031 in corporate taxes since 2022.
Best year ever: 2022, with € 86,192 profit.
On average € 96,300 of value added per employee in 2025.
A new publication or filing at APOTHEEK ROGGEN ZAVENTEM? We notify you, reason included.
Follow APOTHEEK ROGGEN ZAVENTEMDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of R2 FARMA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
APOTHEEK ROGGEN ZAVENTEMBehind APOTHEEK ROGGEN ZAVENTEM are Tim Roosens and R2 Farma BV. The shares are held by R2 FARMA (99%).
Directors
According to the 2025 annual accounts
Shareholders
R2 FARMA · holding of Tim Roosens
99%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Vilvoordelaan 72
1930 Zaventem
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
DSTNY-BACKBONE International Backbone, BE
Website info
Features
Security
Details
- Company number
- 0443.149.052
- VAT number
- BE 0443.149.052
- Registered office
- Vilvoordelaan 72, 1930 Zaventem
- Names & denominations
- APOTHEEK ROGGEN ZAVENTEM
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 1 February 1991
- Peppol
- Active · Active since 1 Jan 2001
- Contact
- apotheekroggen.be
- Activities · NACE
Apothekers
Detailhandel in farmaceutische producten